Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer

European Journal of Surgical Oncology

Volumn 35, Issue 12, 2009, Pages 1268-1272

  Zingg, U ^a   Montani, M ^b   Frey, D M ^a   Dirnhofer, S ^c   Went, P ^b   Oertli, D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Esophagus; Neoadjuvant radio chemotherapy; Squamous cell cancer; Tumor infiltrating lymphocytes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CISPLATIN; FLUOROURACIL; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70449129917     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.07.002     Document Type: Article

References (28)

1. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
2. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival and outcome. Ann Surg 240 (2004) 962-974
3. Zhang L., Conejo-Gracia J.R., Katsaros D., et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348 (2003) 203-213
4. + tumor-infiltrating lymphocytes and a high CD8/regulatory T cell ratio are associated with favourable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102 (2005) 18538-18543
5. + tumor-infiltration lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28 (2004) e26-e31
6. + regulatory T cells suppress anti-tumor responses in patients with colorectal cancer. PloS One 1 (2006) e129
7. + T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 63 (2003) 1555-1559
8. + T cell infiltrations in esophageal carcinomas. Cancer Res 61 (2001) 3932-3936
9. Ikeguchi M., Saito H., Katano K., et al. Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. Oncology 54 (1997) 311-317
10. + regulatory T cells in patients with gastrointestinal malignancies. Cancer 98 (2003) 1089-1099
11. + regulatory T cells at single-cell level. Eur J Immunol 35 (2005) 1681-1691
12. + regulatory T cells. Nat Immunol 4 (2003) 330-336
13. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10 (2004) 942-949
14. Wolf D., Wolf A.M., Rumpold H., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11 (2005) 8326-8331
15. + T-cell subpopulations in head and neck cancers. Clin Cancer Res 12 (2006) 465-472
16. Yoshioka T., Miyamoto M., Cho Y., et al. Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell cancer. Br J Cancer 98 (2008) 1258-1263
17. Kang D.H., Weaver M.T., Park N.J., et al. Significant impairment in immune recovery after cancer treatment. Nurs Res 58 (2009) 105-114
18. + regulatory T cells. Clin Cancer Res 14 (2008) 2413-2420
19. Yamamoto T., Kimura T., Ueta E., et al. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 64 (2003) 407-415
20. + tumor-infiltrating T-cells in oral squamous cell carcinoma. Oncol Rep 15 (2006) 757-763
21. Schaue D., Comin-Anduix B., Ribas A., et al. T-cell responses to surviving in cancer patients undergoing radiation therapy. Clin Cancer Res 14 (2008) 4883-4890
22. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73 (1994) 2680-2688
23. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006) 1960-1964
24. Cao M., Cabrera R., Xu Y., et al. Gamma irradiation alters the phenotype and function of CD4(+)CD25(+) regulatory T cells. Cell Biol Int 33 (2009) 565-571
25. Mozaffari F., Lindemalm C., Choudhury A., et al. Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study. Cancer Immunol Immunother 58 (2009) 111-120
26. Murta E.F., de Andrade J.M., Falcao R.P., et al. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 86 (2000) 403-407
27. + regulatory T cells with improved survival in germinal center-like large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93 (2008) 193-200
28. Tzankov A., Bourgau C., Kaiser A., et al. Rare expression of T-cell markers in classical Hodgkin's lymphoma. Mod Pathol 8 (2005) 1542-1549